Dosage and usage of Nerandomilast-Jascayd

Nerandomilast - Jascayd is a drug used to treat idiopathic pulmonary fibrosis (IPF). The accuracy of its usage and dosage is crucial to the efficacy of the drug and the safety of patients.

Based on current treatment guidelines, the recommended dose of namilast is 18 mg twice daily, usually recommended at an interval of approximately 12 hours. This dose can be taken before or after meals, and patients can choose according to their personal lifestyle habits. When used with pirfenidone, the recommended dose remains 18 mg twice daily and the dose should never be reduced to 9 mg twice daily. For those patients who cannot tolerate 18 mg daily, physicians may consider adjusting the dose to 9 mg twice daily, but this adjustment does not apply to patients taking namilast and pirfenidone concurrently.

In terms of medication management, patients should swallow the tablets whole when taking Namilast tablets, or they can choose to disperse the tablets in water. If the patient misses a dose at a certain point in time, he should take the next dose normally at the next scheduled time. It is not recommended to take the missed dose. This can avoid possible adverse reactions caused by improper dosage. In addition, it is worth noting that the maximum recommended dose of namilast tablets is 18 mg twice daily. Exceeding this dose may increase the risk of side effects.

In some special circumstances, dosage adjustments may be necessary. For example, it is recommended that the dose of namilast be reduced to 9 mg twice daily when patients are receiving concomitant use of strong CYP3A **. When used together with moderate or weak CYP3A inhibitors, it is not recommended to adjust the dose of namilast, and patients should continue to take it at the original dose.

By following these usage and dosage guidelines, patients can more effectively take advantage of the therapeutic effects of nomilast while reducing the risk of side effects and improving quality of life. Patients should maintain close communication with their doctors during medication so that treatment plans can be adjusted in a timely manner when necessary.

Reference materials:https://www.drugs.com/jascayd.html